Ampio raises $16.9M as it advances PhIII premature ejaculation drug
06:12 EDT 16 Jul 2012 | SCRIP
Ampio Pharmaceuticals, a development-stage company, initially raised $15 million which was boosted to $16.9 million by the exercise of overallotments by brokers. The shares were offered at $3.25, an 8.5% discount to the closing price of $3.66 on 12....
Original Article: Ampio raises $16.9M as it advances PhIII premature ejaculation drug
More From BioPortfolio on "Ampio raises $16.9M as it advances PhIII premature ejaculation drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
